Sign in

CIK 0001831828

  • Large accelerated filer

Vera Therapeutics, Inc.

Sign in to watch
Ticker
VERA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812744449
Phone
+1 650-770-0077
Business address
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,334,142
in 2 filings, $1.3M under 10b5-1 plans

Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Fordyce Marshall −$1.3M PRESIDENT AND CEO sold 14% of stake
Date Insider Transaction Shares Price Value Owned after
2023-02-15 Grant Sean Chief Financial Officer Grant or award · Stock Option (right to buy) +200,000 200,000
2023-02-15 Lin Celia Chief Medical Officer Grant or award · Stock Option (right to buy) +100,000 100,000
2023-02-15 Fordyce Marshall President and CEO Grant or award · Stock Option (right to buy) +450,000 450,000
2023-02-13 SEIDENBERG BETH C Director Purchase +10,072 $7.20 $72K 1,664,702
2023-02-09 SEIDENBERG BETH C Director Purchase +400 $7.25 $3K 1,654,630
2023-02-08 SEIDENBERG BETH C Director Purchase +45,357 $7.22 $327K 1,654,230
2023-02-07 SEIDENBERG BETH C Director Purchase +87,956 $7.08 $623K 1,608,873
2023-02-06 Young Joseph R SVP, Finance, Chief Acct Offcr Purchase +5,714 $7.00 $40K 22,679
2023-02-06 Grant Sean Chief Financial Officer Purchase +14,285 $7.00 $100K 49,933
2023-02-06 SEIDENBERG BETH C Director Purchase +131,602 $7.03 $925K 1,520,917
2023-02-06 Sofinnova Venture Partners X, L.P. 10% owner Purchase +285,714 $7.00 $2.0M 3,467,156
2023-02-06 Longitude Capital Partners IV, LLC 10% owner Purchase +1,714,285 $7.00 $12.0M 1,714,285
2023-02-06 ENRIGHT PATRICK G Director Purchase +1,714,285 $7.00 $12.0M 1,714,285
2023-02-03 SEIDENBERG BETH C Director Purchase +46,163 $7.24 $334K 1,389,315
2022-12-16 Curley Joanne Chief Development Officer Option exercise +1,429 $2.90 $4K 28,250
2022-12-16 Curley Joanne Chief Development Officer Sale −1,429 $19.12 $27K 26,821
2022-12-16 Curley Joanne Chief Development Officer Option exercise +783 $2.90 $2K 27,604
2022-12-16 Curley Joanne Chief Development Officer Sale −783 $20.17 $16K 26,821
2022-12-16 Curley Joanne Chief Development Officer Option exercise · Stock Option (right to buy) −2,212 35,801
2022-12-13 Curley Joanne Chief Development Officer Option exercise +11,733 $11.00 $129K 38,554

Page 18 of 30 · 581 trades